Peroxisome-associated enzymes and serum lipids in tumour-bearing rats treated with peroxisome-proliferating agents
- PMID: 6431985
- DOI: 10.1016/0006-2952(84)90630-0
Peroxisome-associated enzymes and serum lipids in tumour-bearing rats treated with peroxisome-proliferating agents
Abstract
Xenobiotic induction of liver peroxisomes is associated with hypolipidemia. To test the involvement of the peroxisome proliferation with the hypolipidemia, male rats were inoculated in the groin with five different tumors: an aflatoxin-induced hepatoma, a lasiocarpine-induced hepatoma, an actinomycin-D-induced mesothelioma, a lasiocarpine-induced squamous cell carcinoma, and a methylnitrosourea-induced fibrosarcoma. After the tumours reached a suitable size, the rats were fed diets containing the peroxisome-proliferating hypolipidemic agents tibric acid (2-chloro-5-[3,5-dimethylpiperidinosulfonyl] benzoic acid) or Wy-14,643 ([4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid) for 2 weeks. Liver and tumor tissues were then assayed for the peroxisome-associated enzymes, catalase and carnitine acetyltransferase, and correlated with serum levels of triglyceride and cholesterol. The presence of the tumors caused a predictable decrease in liver catalase and a slight elevation of liver carnitine acetyltransferase. Serum cholesterol was elevated slightly, while serum triglyceride levels were elevated, unchanged, or decreased in the tumor-bearing rats maintained on control diet. Inclusion of the xenobiotics in the diet caused increases in liver weight, catalase, and carnitine acetyltransferase. Serum triglycerides were decreased in the three groups which were not already decreased, but a decrease in serum cholesterol was only found in one group after only one of the treatments. The latter finding demonstrates that peroxisomal enzyme induction can be dissociated from the decrease in serum cholesterol. The data were further evaluated by testing for correlations between the changes in these components, comparing changes within groups and between groups. These correlations indicate an inverse biological association between liver catalase and serum cholesterol and between liver carnitine acetyltransferase and serum triglyceride. The latter correlation was inverse only for comparisons between groups, suggesting that carnitine acetyltransferase activity is associated with serum triglycerides only during the perturbational state.
Similar articles
-
Hepatic effects of some [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (WY-14,643) analogs in the mouse.Arch Int Pharmacodyn Ther. 1977 Jan;225(1):51-7. Arch Int Pharmacodyn Ther. 1977. PMID: 851495
-
Hepatic peroxisome proliferation: induction by BR-931, a hypolipidemic analog of WY-14,643.Arch Int Pharmacodyn Ther. 1978 Jul;234(1):4-14. Arch Int Pharmacodyn Ther. 1978. PMID: 708142
-
Hepatic peroxisome proliferation: induction by two novel compounds structurally unrelated to clofibrate.Science. 1975 Nov 21;190(4216):787-9. doi: 10.1126/science.1198095. Science. 1975. PMID: 1198095
-
Evaluation of selected hypolipidemic agents for the induction of peroxisomal enzymes and peroxisome proliferation in the rat liver.Hum Toxicol. 1983 Jan;2(1):27-48. doi: 10.1177/096032718300200103. Hum Toxicol. 1983. PMID: 6840792
-
Catalase: its role in xenobiotic detoxification.Pharmacol Ther. 1989;44(2):297-307. doi: 10.1016/0163-7258(89)90069-7. Pharmacol Ther. 1989. PMID: 2519346 Review.
Cited by
-
Effect of KCD-232, a new hypolipidemic agent, on serum lipoprotein changes in hepatoma-bearing rats.Lipids. 1985 Jul;20(7):420-4. doi: 10.1007/BF02534232. Lipids. 1985. PMID: 4033362
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical